Related Experiment Video

Updated: May 26, 2026

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides (CHIPS)
06:34

Synthesis of Antiviral Tetrahydrocarbazole Derivatives by Photochemical and Acid-catalyzed C-H Functionalization via Intermediate Peroxides (CHIPS)

Published on: June 20, 2014

Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase

Giuseppe Manfroni1, Francesco Meschini, Maria Letizia Barreca

  • 1Dipartimento di Chimica e Tecnologia del Farmaco, University of Perugia, 06123 Perugia, Italy. giuseppe.manfroni@unipg.it

Bioorganic & Medicinal Chemistry
|December 27, 2011
PubMed

Insights

Researchers identified new compounds targeting the Hepatitis C virus (HCV) NS5B polymerase. These novel chemotypes show promise as allosteric inhibitors, potentially leading to new treatments for HCV infection and liver disease.

Area of Science:

  • Medicinal Chemistry
  • Virology
  • Drug Discovery

Background:

  • Hepatitis C virus (HCV) infection is a primary cause of liver failure and hepatocellular carcinoma.
  • The NS5B polymerase is a critical viral protein and a key target for antiviral drug development.

Purpose of the Study:

  • To discover novel chemotypes as allosteric inhibitors of the HCV NS5B polymerase.
  • To synthesize and evaluate a series of 1-oxo-1H-pyrido[2,1-b][1,3]benzothiazole-4-carboxylate derivatives for anti-HCV activity.

Main Methods:

  • Chemical synthesis of pyrido[2,1-b][1,3]benzothiazole derivatives.
  • In vitro biochemical assays to determine NS5B polymerase inhibition (IC50).
  • In cellulo studies to assess anti-HCV efficacy.
  • Molecular modeling to predict binding sites.

Main Results:

  • Several synthesized compounds demonstrated inhibitory activity against HCV NS5B polymerase.
  • IC50 values for the most potent compounds ranged from 11 to 23 μM.
  • Molecular modeling and biochemical data suggest the thumb domain of NS5B is a potential target site.

Conclusions:

  • The study identified a new class of allosteric NS5B inhibitors based on the pyrido[2,1-b][1,3]benzothiazole scaffold.
  • These compounds represent promising leads for developing novel therapeutics against Hepatitis C virus.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...